Company Description
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States.
It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.
The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data.
It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products.
The company was incorporated in 2006 and is headquartered in San Francisco, California.
| Country | United States |
| IPO Date | Oct 20, 2016 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 2,000 |
| CEO | Quentin S. Blackford |
Contact Details
Address: 699 8th Street San Francisco, California United States | |
| Website | https://www.irhythmtech.com |
Stock Details
| Ticker Symbol | IRTC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001388658 |
| CUSIP Number | 450056106 |
| ISIN Number | US4500561067 |
| Employer ID | 20-8149544 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Quentin S. Blackford | President, Chief Executive Officer & Director |
| Chad M. Patterson | Chief Commercial Officer |
| Daniel G. Wilson | Executive Vice President of Corporate Development & Investor Relations |
| Dr. Minang P. Turakhia M.D., M.S. | Chief Medical & Scientific Officer and Executive Vice President of Product Innovation |
| Marc Rosenbaum | Senior Vice President of Finance & Chief Accounting Officer |
| Mervin Smith | Executive Vice President of Business Operations |
| Patrick Michael Murphy J.D. | Chief Business & Legal Officer |
| Stephanie Zhadkevich | Director of Investor Relations |
| Sumi Shrishrimal | Executive Vice President & Chief Risk Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Jan 08, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Dec 27, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 07, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 05, 2024 | 4 | Filing |
| Nov 05, 2024 | 4 | Filing |